Polycystic Kidney, Autosomal Recessive
1 clinical trials · Condition
◉ Watch Polycystic Kidney, Autosomal Recessive
| Record | Firm | Date |
|---|---|---|
| A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD) (NCT03096080) | Kadmon Corporation, LLC | 2017-08-24 |
Track Polycystic Kidney, Autosomal Recessive automatically
Every clearance here is in the API, with alerts when new ones post.